1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

Overview of attention for article published in Radiation Oncology, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 7 X users, with an upper bound of 28,218 followers.

@SbrtSean @AshwinShindeMD @seanmmcbride CTV-PTV: 5mm excluding posteriorly with 3mm. 👍 We did in this way with linac-based #SBRT for #prostatecancer and also with #MRlinac https://t.co/dCCvSvWKbM

14 Jan 2021

Reply Repost Favourite

@JinzhongYangPhD @Elekta Greetings and many thanks for citing some of my papers on MRlinac 👉the review of MRlinac as ref 7 and my center experience 🇮🇹 on #SBRT for #ProstateCancer by @Elekta Unity as ref 12 that you can find here: https://t.co/dCCvSvWKbM

25 Dec 2020

Reply Repost Favourite

RT @alongi_filippo: @SbrtSean You are right👍! PROMS are really usefull to really understand QoL and tolerability of SBRT. This is our recen…

09 Aug 2020

Reply Repost Favourite

@SbrtSean You are right👍! PROMS are really usefull to really understand QoL and tolerability of SBRT. This is our recent experience on that: https://t.co/dCCvSvWKbM

09 Aug 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.